Navigating Preclinical Infection Models: Fundamentals in In Vitro and In Vivo Systems — ESCMID EPASG Webinar

    Dates:
    Organizer:
    ESCMID Study Group for PK/PD of Anti-Infectives (EPASG); endorsed by IATDMCT
    Location:
    Online
    Specialty:
    Infectious Disease
    Format:
    Online

    Navigating Preclinical Infection Models: Fundamentals in In Vitro and In Vivo Systems is a one-hour live webinar from the ESCMID Study Group for PK/PD of Anti-Infectives (EPASG), endorsed by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT). It takes place online on Thursday 10 December 2026, 15:00–16:00 CET (09:00 US Eastern Time). In vitro and animal

    Navigating Preclinical Infection Models: Fundamentals in In Vitro and In Vivo Systems — ESCMID EPASG Webinar

    Navigating Preclinical Infection Models: Fundamentals in In Vitro and In Vivo Systems — ESCMID EPASG Webinar1 / 1

    1 photo · tap to enlarge

    Dec 10 – Dec 10, 2026See all December 2026 events

    Navigating Preclinical Infection Models: Fundamentals in In Vitro and In Vivo Systems — ESCMID EPASG Webinar

    Listed 20 Nov 2026

    About this event

    Navigating Preclinical Infection Models: Fundamentals in In Vitro and In Vivo Systems is a one-hour live webinar from the ESCMID Study Group for PK/PD of Anti-Infectives (EPASG), endorsed by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT). It takes place online on Thursday 10 December 2026, 15:00–16:00 CET (09:00 US Eastern Time).

    In vitro and animal models are invaluable tools throughout the evaluation and development of anti-infectives, including the selection of dosing regimens. This webinar introduces the core principles of these preclinical systems, helps participants interpret their results critically, and highlights the key translational opportunities and gaps between laboratory models and patients.

    Programme

    1. In Vitro PK/PD Models: Current Role, Challenges, and Future Perspectives — Sandrine Marchand, Université de Poitiers, France This talk reviews the range of in vitro PK/PD models, from checkerboard assays and time-kill curves to dynamic systems such as the hollow-fiber infection model (HFIM). Each model is presented with its advantages and limitations, with a deeper look at the major limitations common to many of them.

    2. Animal Models from PK/PD Index to Efficacy and Toxicity in a Changing Regulatory Landscape — Marc Scheetz, Midwestern University, Illinois, USA Building on the in vitro session, this presentation examines what animal infection models add when the host matters: deriving PK/PD indices, humanizing drug exposure, accounting for immune status, and bridging efficacy and toxicity findings to patients. It also reviews recent US and European initiatives to reduce animal testing and considers how animal studies might be replaced.

    Chairs

    • Christina König — University Medical Center Hamburg-Eppendorf, Germany
    • Birgit Koch — University of Groningen, Netherlands

    Who should attend Infectious diseases physicians and pharmacists, clinical microbiologists, clinical pharmacologists, TDM specialists, drug-development scientists, regulatory professionals and trainees with an interest in antimicrobial pharmacokinetics/pharmacodynamics and translational research.

    Registration Register through the official Zoom webinar registration page. No fee, CME credits or recording details have been published for this webinar.

    Ratings & Reviews

    No ratings yet
    FREE WEEKLY DIGEST

    Never miss a CME event

    Get curated events for your specialty — every week